U.S. Capital Markets Stock News

Coca-Cola FEMSA. de has delivered a strong 141.1% return over the past 5 years, yet the current valuation checks and intrinsic value estimate suggest the stock may still trade at a discount to what its cash flows imply. The 141.1% 5 year return highlights that long term shareholders have already seen substantial gains, which raises the bar for any further upside to be justified by fundamentals. Expectations for steady cash generation from Coca-Cola FEMSA. de's beverage portfolio can support...

Recent trading in iRhythm Holdings (IRTC) has caught investor attention, with the stock closing at US$112.55 and posting declines over the past week, month, and past 3 months, raising questions about how current pricing aligns with fundamentals. See our latest analysis for iRhythm Holdings. For context, iRhythm Holdings’ recent 1 day share price decline of 5.17% and 7 day share price decline of 10.02% sit against a year to date share price return that is down 35.77%, while the 5 year total...

Graphic Packaging Holding (GPK) has drawn fresh attention after launching PaceSetter Ridgeline, an uncoated recycled paperboard product made from 100% recycled fiber and produced at its Waco, Texas mill. See our latest analysis for Graphic Packaging Holding. Despite the launch of PaceSetter Ridgeline and renewed focus on recycled paperboard, Graphic Packaging Holding’s shares trade at $10.33, with the share price down over the year to date, while the 1 year total shareholder return has also...

NOV (NOV) is back on investors’ radar after recent analysis highlighted improving earnings projections, growing market share tied to its drilling technologies, and an order backlog that offers clearer revenue visibility, despite ongoing valuation and margin questions. See our latest analysis for NOV. At a share price of $19.30, NOV has a 7 day share price return of 5.58% after a softer 30 day share price return of 8.66% and a 1 year total shareholder return of 54.42%. Together, these figures...

D.R. Horton stock has delivered a 77.3% return over the past five years. Current checks suggest the shares may still sit below an intrinsic value estimate that points to some undervaluation, and this view is also supported by earnings multiples that lean the same way. Over five years, D.R. Horton has returned 77.3%, which puts recent short-term weakness in a longer-run context for anyone weighing potential valuation upside. Stronger cash generation from its homebuilding operations can...

Independent Bank Corp. recently announced it would release its second-quarter 2026 earnings on July 16, with analysts expecting earnings of US$1.77–US$1.78 per share and revenue of about US$257.73–US$258.95 million. These expectations, alongside a fresh US$0.64 per-share dividend declaration and ongoing analyst estimate revisions, are sharpening investor focus on the bank’s near-term performance. We’ll now examine how the upcoming earnings release and stronger earnings expectations may...

Iridium PNT ASIC launch puts assured timing and location in focus Iridium Communications (IRDM) has moved its assured positioning, navigation, and timing technology from concept to commercial product, launching the Iridium PNT ASIC amid demand from more than 150 organizations across critical infrastructure sectors. See our latest analysis for Iridium Communications. Iridium Communications has paired this product milestone with strong share price momentum, with a 90 day share price return of...

JetBlue Airways (JBLU) is back in focus after launching a new pay later program with ClarityPay that embeds financing into the booking journey and ties directly into its TrueBlue loyalty ecosystem. See our latest analysis for JetBlue Airways. The new ClarityPay partnership comes as JetBlue Airways trades at US$5.33, with the share price showing a 16.12% year to date gain but a 65.28% decline in 5 year total shareholder return. This indicates that recent momentum has not reversed longer term...

Moderna stock has surged 118.5% year to date, yet the company screens as expensive on Simply Wall St's broader valuation checks. This raises a clear question about how much optimism is already built into the current price. The 118.5% gain so far this year suggests investors are pricing in a lot of confidence around Moderna's pipeline and future vaccine revenues. Expectations around upcoming regulatory decisions on its vaccines can support that optimism, but the stock's history of deeper...

Entergy’s carbon capture alliance with Mitsubishi: what investors should watch Entergy (ETR) is drawing fresh attention after signing a memorandum of understanding with Mitsubishi Heavy Industries Group to advance gas turbine, carbon capture and storage projects, while targeting a 50% reduction in overall costs. See our latest analysis for Entergy. Entergy’s recent carbon capture agreement arrives as the stock trades at $115.41, with a year to date share price return of 22.96% and a 5 year...

Teladoc Health stock has had a tough run over the past five years, yet current valuation checks now point to the shares trading at a discount, with the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples both suggesting the market price may sit below what the company’s fundamentals imply. Over the past five years Teladoc Health has declined 94.0%, which puts the current valuation in the context of a long period of weak shareholder returns. Investors are watching how the...

New U.S. tariffs of 25% on thousands of Brazilian imports are set to reshape how agricultural and industrial goods move around the world, with roughly $15b in trade directly in the crosshairs. For investors, that kind of shock can quickly split stocks into potential winners and potential losers as input costs, export routes, and customer demand all adjust. This article walks through three stocks exposed to the tariff story, showing how one could find support from shifting trade flows while...

Live Nation Entertainment (LYV) is back in focus after fresh valuation work using Discounted Cash Flow and revenue multiples suggested the stock trades below an estimated intrinsic value, despite recording a 135.8% total return over the past 5 years. See our latest analysis for Live Nation Entertainment. Over the past year, Live Nation Entertainment has combined a 24.95% year to date share price return with a 24.30% total shareholder return over 12 months. Its 135.82% total shareholder return...

In early July 2026, Thermo Fisher Scientific’s Board authorized a quarterly cash dividend of US$0.47 per share and saw its RapidINTEL Plus DNA cartridge approved by the FBI’s National DNA Index System, while also joining Arcturus Therapeutics to support Phase 3 development and potential commercialization of the ARCT-032 mRNA cystic fibrosis therapy. Together, these developments highlight Thermo Fisher’s mix of shareholder returns, advanced forensic tools linked to the national CODIS...

Kulicke and Soffa Industries stock has delivered a very strong 217.6% return over the past year, yet the current valuation checks suggest the shares are priced at a premium rather than standing out as a clear bargain. Over the last 12 months, Kulicke and Soffa Industries has returned 217.6%, which puts extra focus on whether recent gains already reflect investor optimism. Recent strength in demand across key end markets can support higher earnings expectations, but any disappointment in...

Amkor Technology (AMKR) is back on investor watchlists after a fresh insider trading plan filing, as Chief Financial Officer Megan Faust disclosed plans to sell up to 1,000 shares of common stock acquired through performance awards. See our latest analysis for Amkor Technology. Amkor Technology’s recent insider sales and valuation debate sit against a share price that has climbed 63.56% year to date, with a 90 day share price return of 17.55% but a 30 day share price return that has fallen...

Options Activity and Trial Milestone Put SELLAS Life Sciences in Focus SELLAS Life Sciences Group (SLS) is back on radar after a 1% overnight move tied to fresh institutional interest, heavier call options trading, and a key milestone in its Phase 3 REGAL AML trial. See our latest analysis for SELLAS Life Sciences Group. At a share price of $13.39, SELLAS Life Sciences Group has seen a 71% 1 month share price return and a 173% 3 month share price return, while the 1 year total shareholder...

June traffic update and what it might mean for Copa Holdings stock Copa Holdings (NYSE:CPA) just released preliminary operating results for June 2026, showing higher available seat miles and revenue passenger miles, alongside a lower load factor. This gives investors fresh data on capacity use and demand. See our latest analysis for Copa Holdings. Copa Holdings shares have gained 22.1% over the past 90 days and delivered a 1 year total shareholder return of 41.8%. The recent June traffic...

Ally Financial recently appointed Mark Mathewson as Chief Information and Data Officer, effective July 20, 2026, to lead its enterprise-wide technology and data organization for the all-digital bank and auto lender. By bringing in a veteran technologist with deep financial services experience from Capital One and Fannie Mae, Ally is signaling a sharper focus on strengthening its core technology, data analytics and digital infrastructure at a time when these capabilities are increasingly...

Executive transition at General Dynamics and what it means for investors General Dynamics (GD) has flagged a coming shift in its top legal office, with long-time senior vice president and general counsel Greg Gallopoulos set to retire at the end of 2026. Vice president and deputy general counsel Nick Barnaby is slated to step into the senior vice president and general counsel role on January 1, 2027. This timeline gives investors an extended period to assess this governance transition...

Carvana (CVNA) is back in focus after expanding same-day delivery and pickup to the greater Milwaukee area. This move draws attention to how its online used-car model and logistics may influence the stock. See our latest analysis for Carvana. The Milwaukee launch comes as Carvana’s recent momentum is mixed, with the 1 day share price return of 8.29% and 1 month share price return of 9.80% contrasting with a share price decline of 12.08% year to date and a very large 3 year total shareholder...

Share repurchase update gives investors fresh data point Novo Nordisk (NVO) has updated investors on its ongoing share repurchase programme, with plans to buy back B shares for up to DKK 11.2 billion through 1 February 2027. See our latest analysis for Novo Nordisk. At a share price of $49.07, Novo Nordisk has seen a 30 day share price return of 11.83% and a 90 day share price return of 20.24%, yet its 1 year total shareholder return is down 24.60%. This suggests that recent momentum...

In early June 2026, Amgen voluntarily initiated nationwide US recalls of certain Sensipar (cinacalcet) and Corlanor (ivabradine) tablet lots after FDA-identified CGMP deviations and foreign substances, with the actions classified as Class II and still ongoing as of July 15, 2026. The combination of manufacturing-quality issues across multiple lots and the absence of a public press release for some recalls raises important questions about operational oversight and how Amgen manages regulatory...

Product launch puts Del Monte’s ingredient business in focus Del Monte (DMC) has drawn fresh attention after partnering with Treatt on a new line of fruit-derived beverage extracts that use upcycled pineapple, watermelon, mango and cantaloupe materials from its existing processing operations. See our latest analysis for Del Monte. Despite the new ingredient launch and an upcoming second quarter 2026 earnings release, Del Monte’s recent momentum has been soft. The share price is down 31.6%...